{"disease":{"id":"clostridioides-difficile-infection","name":"clostridioides difficile infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03595553","title":"Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Summit Therapeutics","has_results":true},{"nct_id":"NCT05330182","title":"LMN-201 for Prevention of C. Difficile Infection Recurrence","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":375,"lead_sponsor_name":"Lumen Bioscience, Inc.","has_results":false},{"nct_id":"NCT06859437","title":"Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT06979609","title":"Secondary Prevention of Clostridioides Difficile Using Vancomycin","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT06788769","title":"Study of Clostridioides Difficile in Infants","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Westlake University","has_results":false},{"nct_id":"NCT03183141","title":"ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":263,"lead_sponsor_name":"Seres Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04305769","title":"Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT07285213","title":"Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":230,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05266807","title":"Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Benoit Guery","has_results":false},{"nct_id":"NCT04725123","title":"Addressing Personalized Needs in Clostridioides Difficile Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":false},{"nct_id":"NCT05257538","title":"FMT in Initial CDI","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Turku University Hospital","has_results":false},{"nct_id":"NCT03895593","title":"Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT05852587","title":"Xylitol Use for Decolonization of C. Difficile in Patients With IBD","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":99,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07401680","title":"Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":85,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03788434","title":"Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Vedanta Biosciences, Inc.","has_results":true},{"nct_id":"NCT07458984","title":"FMT Capsules for rCDI","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT06799039","title":"Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":69,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07250724","title":"C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Bactolife A/S","has_results":false},{"nct_id":"NCT06019312","title":"L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Medical University of Gdansk","has_results":false},{"nct_id":"NCT06306014","title":"Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04675723","title":"The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05304715","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":true},{"nct_id":"NCT04781387","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Crestone, Inc","has_results":true},{"nct_id":"NCT04885946","title":"Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection","phase":"NA","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Christian Hvas","has_results":false},{"nct_id":"NCT07496502","title":"Effect of Oral Microbiota on MDRO Decolonization","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false},{"nct_id":"NCT06370884","title":"Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT06692179","title":"An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT06884748","title":"Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT05612672","title":"Evaluation of GeoHAI Implementation","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT05320068","title":"Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Julia Orígüen","has_results":false},{"nct_id":"NCT04668014","title":"The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05739825","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06639997","title":"Safety and Tolerability of AZD5148 in Japanese Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06836427","title":"CMTS0929 for Clostridioides Difficile Infection","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT05526807","title":"Ursodeoxycholic Acid in C. Difficile Infection","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Nottingham University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT06536465","title":"The Clostridioides Difficile Trial of REC-3964","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Recursion Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT04802837","title":"Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Summit Therapeutics","has_results":true},{"nct_id":"NCT04679324","title":"The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02437500","title":"Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Seres Therapeutics, Inc.","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}